Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2000
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370391A1 Method for down-regulating il5 activity
11/02/2000CA2370298A1 Peptide homodimers or peptide heterodimers derived from interleukin 12
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369999A1 Enzymatically activated polymeric drug conjugates
11/02/2000CA2369579A1 Controlled release of growth factors from heparin containing matrices
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271733A CpG oligonucleotide with specific immunostimulation activity to human immune cell
11/01/2000CN1271603A Health-care cordyceps-pollen food and its preparing process
11/01/2000CN1271602A Health-care pilose antler-pollen food and its preparing process
11/01/2000CN1271601A Health-care tendrilled fritillary bulb-pollen food and its preparing process
11/01/2000CN1271600A Health-care fleece flower root-pollen food and its preparing process
11/01/2000CN1271599A Health-care tortoise-turtle-pollen food and its preparing process
11/01/2000CN1271598A Health-care notoginseng-pollen food and its preparing process
11/01/2000CN1271597A Health-care saffron-notoginseng-pollen food and its preparing process
11/01/2000CN1271596A Health-care human placenta-pollen food and its preparing process
11/01/2000CN1271595A Health-care ginseng-pollen food and its preparing process
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
11/01/2000CN1057915C Immunologic adjuvant
10/2000
10/31/2000US6140492 Antisense transcript expressed in B lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
10/31/2000US6140467 Ligand for herpes simplex virus entry mediator and methods of use
10/31/2000US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals
10/31/2000US6140363 Administering rosmarinic acid, its derivative or prunella vulgaris extract for suppressing immune response for treatment, prevention, or diagnosis of rejection of transplanted organ or tissue, chronic rejection
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase
10/31/2000US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor
10/31/2000US6140124 Nucleotide sequences which target untranslated regions, translation start site and translation termination position; for diagnosis and treatment of tumors, inflammation and arthritis; antitumor agents; inflammatory agents
10/31/2000US6140114 Defective viral vaccine particles obtained in vivo or ex vivo
10/31/2000US6139864 A food or medicine containing a zinc compound and an antimicrobially effective amount of a sugar alcohol mixture without complexing with zinc compound; treatment and prevention of viral cold
10/31/2000CA2185112C Humanized monoclonal antibodies against human interleukin-4
10/31/2000CA2152621C Pharmaceutical compositions comprising contignasterol compounds
10/27/2000CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses
10/26/2000WO2000063393A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000WO2000063374A1 Synthetic transmembrane components
10/26/2000WO2000063372A1 Synthetic signalling molecules
10/26/2000WO2000063369A2 Gene therapy
10/26/2000WO2000063363A1 Peptide from antigen muc-1 for triggering an immune response to tumor cells
10/26/2000WO2000063361A2 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000WO2000063351A2 Carbohydrate-modifying enzymes
10/26/2000WO2000063253A1 Agp-1 fusion protein compositions and methods
10/26/2000WO2000063252A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor
10/26/2000WO2000063251A1 Composition and method for modulating dendritic cell-t cell interaction
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063241A2 Methods and compositions for modulating an immune response
10/26/2000WO2000063230A2 49 human secreted proteins
10/26/2000WO2000063228A1 Ent-steroids as selectively active estrogens
10/26/2000WO2000063221A2 Galectin 11
10/26/2000WO2000063210A1 Morphinoid compounds
10/26/2000WO2000063204A2 Substituted azoles
10/26/2000WO2000063181A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins
10/26/2000WO2000062818A1 Differentiation of monocytes into functional dendritic cells
10/26/2000WO2000062813A2 Cationic peg-lipids and methods of use
10/26/2000WO2000062805A1 A method of reversing thymic atrophy
10/26/2000WO2000062803A2 ppGpp AND pppGpp AS IMMUNOMODULATORY AGENTS
10/26/2000WO2000062801A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
10/26/2000WO2000062800A2 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/26/2000WO2000062791A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000WO2000062788A2 Treatment of hypersensitivity reaction disorders
10/26/2000WO2000062781A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000WO2000062778A1 Cyclic protein tyrosine kinase inhibitors
10/26/2000WO2000062770A1 Compounds useful as phosphotyrosine mimics
10/26/2000WO2000062767A2 Pharmaceutical compositions containing pyridine or pyrimidine derivates for inhibition of cytokine production and secretion
10/26/2000WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
10/26/2000WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/26/2000WO2000062657A2 Improvement of t cell mediated immunity
10/26/2000WO2000047607B1 A synthetic peptide disturbing intracellular signaling
10/26/2000WO2000036089A3 Methods of immunosuppression
10/26/2000WO2000035482A3 Novel adjuvant for subunit or component vaccines
10/26/2000WO2000034444A3 Method and composition for preserving viruses
10/26/2000WO2000034294A3 Tumor necrosis factor receptor homologue-1 ('trh1')
10/26/2000WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
10/26/2000WO2000028045A3 Human hydrolase proteins
10/26/2000WO2000026197A9 Novel inhibitors of impdh enzyme
10/26/2000WO2000025808A8 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
10/26/2000WO2000025746A3 A process for the preparation of suspensions of drug particles for inhalation delivery
10/26/2000WO2000020601A3 Polyketide synthase enzymes and recombinant dna constructs therefor
10/26/2000WO2000018795A3 Compositions and methods for wt1 specific immunotherapy
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
10/26/2000WO2000016801A9 Methods of downmodulating the immune response to therapeutic proteins
10/26/2000DE19918682A1 New recombinant DNA encoding an allergen produced by grasses of the Poaceae family, useful for diagnosis of pollen allergy and for treatment by desensitization
10/26/2000DE19918327A1 Generating donor tolerance in humans, useful for inducing compatibility with xenotransplants, comprises injection of fetus or embryo with donor stem cells
10/26/2000CA2758956A1 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes
10/26/2000CA2371972A1 Ent-steroids as selectively active estrogens
10/26/2000CA2371611A1 Galectin 11
10/26/2000CA2370690A1 Cationic peg-lipids and methods of use
10/26/2000CA2370617A1 Dsp-8 dual-specificity map kinase phosphatase
10/26/2000CA2370453A1 Treatment of hypersensitivity reaction disorders
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370296A1 Improvement of t cell mediated immunity
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2369633A1 A multi-plasmid method for preparing large libraries of polyketides and non-ribosomal peptides
10/26/2000CA2369342A1 Carbohydrate-modifying enzymes
10/26/2000CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk
10/26/2000CA2368839A1 D-form polypeptide which induces immune tolerance and methods of use
10/26/2000CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv)
1 ... 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 ... 1172